论文部分内容阅读
作者报告自１９８８年至１９９６年用气管、支气管隆、突成形术治疗原发性中央型肺癌１９例。其中病变位于右上肺１４例（含侵犯右总支气管及隆突２例），左上肺４例，气管隆突部肿瘤１例。本组行右上叶袖状切除术１２例，左肺上叶袖状切除术４例，右全肺隆突切除＋隆突成形术２例，气管隆突部肿瘤切除＋隆突成形术１例。病理类型：鳞癌细胞１５例，腺癌细胞２例，粘液表皮样癌１例，小细胞肺癌１例。我们认为此手术安全，符合肺癌“二个最大限度”的治疗原则，虽有一定的技术难度，但易于掌握，关键在于手术适应症的选择。
The authors report 19 cases of primary central lung cancer treated with tracheobronchial protuberance from 1988 to 1996. The lesions were located in the right upper lung in 14 cases (including 2 cases of invading right bronchus and carina), 4 cases in the left upper lung, and 1 case in the tracheal bulge tumor. In this group, there were 12 cases of right upper lobe sleeve resection, 4 cases of left upper lobe sleeve resection, 2 cases of right whole lung keel resection + protuberance plasty, and 1 case of tracheal bulge tumor resection + protuberance plasty. . Pathological types: 15 cases of squamous cell carcinoma, 2 cases of adenocarcinoma cells, 1 case of mucoepidermoid carcinoma, and 1 case of small cell lung cancer. We believe that this operation is safe and is in line with the principle of “two maximums” of lung cancer treatment. Although there are certain technical difficulties, it is easy to grasp. The key lies in the choice of surgical indications.